IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques

Vaccine

Volumn 22, Issue 25-26, 2004, Pages 3510-3521

  Villinger, F ^a   Miller, R ^b   Mori, K ^c   Mayne, A E ^a   Bostik, P ^a   Sundstrom, J B ^a   Sugimoto, C ^c   Ansari, A A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

B lymphocytoblast; B LCB; EIA; enzymatic immunosorbent assay; Flu; Flu MP; HIV; human immunodeficiency virus; IL; influenza live attenuated isolate A PR8; influenza matrix protein; interleukin; intravenously; IV; mab; MHC; monoclonal antibody

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FREUND ADJUVANT; RECOMBINANT INTERLEUKIN 15; RECOMBINANT INTERLEUKIN 2; TETANUS TOXOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; EFFECTOR CELL; EXPERIMENTAL ANIMAL; IN VIVO STUDY; INFLUENZA VACCINATION; LYMPHOCYTE PROLIFERATION; MAINTENANCE THERAPY; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; HALF-LIFE; IMMUNIZATION; IMMUNOLOGIC MEMORY; INFLUENZA VACCINES; INTERLEUKIN-15; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MACACA MULATTA; T-LYMPHOCYTES, REGULATORY; TETANUS TOXOID; VACCINES, ATTENUATED;

EID: 3042548953     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.07.022     Document Type: Article

References (53)

1. Whitmire J.K., Ahmed R. Costimulation in antiviral immunity: differential requirements for CD4(+) and CD8(+) T cell responses. Curr Opin Immunol. 12:2000;448-455
2. Blattman J.N., Sourdive D.J., Murali-Krishna K., Ahmed R., Altman J.D. Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection. J Immunol. 165:2000;6081-6090
3. Zinkernagel R.M., Hengartner H. Regulation of the immune response by antigen. Science. 293:2001;251-253
4. Kaech S.M., Wherry E.J., Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. 2:2002;251-262
5. Armstrong T.D., Jaffee E.M. Cytokine modified tumor vaccines. Surg Oncol Clin North Am. 11:2002;681-696
6. Lena P, Villinger F, Giavedoni L, Miller CJ, Rhodes G, Luciw P. Co-immunization of rhesus macaques with plasmid vectors expressing IFN-gamma, GM-CSF, and SIV antigens enhances anti-viral humoral immunity but does not affect viremia after challenge with highly pathogenic virus. Vaccine 2002;19(20 Suppl 4):A69-79.
7. Weigel B.J., Nath N., Taylor P.A., Panoskaltsis-Mortari A., Chen W., Krieg A.M., et al. Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses. Blood. 100:2002;4169-4176
8. Barouch D.H., Santra S., Schmitz J.E., Kuroda M.J., Fu T.M., Wagner W., et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science. 290:2000;486-492
9. Mueller Y.M., Makar V., Bojczuk P.M., Witek J., Katsikis P.D. IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4(+) and CD8(+) effector-memory T cells. Int Immunol. 15:2003;49-58
10. Wherry E.J., Becker T.C., Boone D., Kaja M.K., Ma A., Ahmed R. Homeostatic proliferation but not the generation of virus specific memory CD8 T cells is impaired in the absence of IL-15 or IL-15Ralpha. Adv Exp Med Biol. 512:2002;165-175
11. Becker T.C., Wherry E.J., Boone D., Murali-Krishna K., Antia R., Ma A., et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med. 195:2002;1541-1548
12. Maus M.V., Thomas A.K., Leonard D.G., Allman D., Addya K., Schlienger K., et al. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor CD28 and 4-1BB. Nat Biotechnol. 20:2002;143-148
13. Liebowitz D.N., Lee K.P., June C.H. Costimulatory approaches to adoptive immunotherapy. Curr Opin Oncol. 10:1998;533-541
14. Li X.C., Demirci G., Ferrari-Lacraz S., Groves C., Coyle A., Malek T.R., et al. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat Med. 7:2001;114-118
15. Waldmann T.A., Dubois S., Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity. 14:2001;105-110
16. Okamoto Y., Douek D.C., McFarland R.D., Koup R.A. Effects of exogenous interleukin-7 on human thymus function. Blood. 99:2002;2851-2858
17. Yada S., Nukina H., Kishihara K., Takamura N., Yoshida H., Inagaki-Ohara K., et al. IL-7 prevents both caspase-dependent and -independent pathways that lead to the spontaneous apoptosis of i-IEL. Cell Immunol. 208:2001;88-95
18. Soares M.V., Borthwick N.J., Maini M.K., Janossy G., Salmon M., Akbar A.N. IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire. J Immunol. 161:1998;5909-5917
19. Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 264:1994;965-968
20. Giri J.G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S., et al. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:1994;2822-2830
21. Refaeli Y., Van Parijs L., London C.A., Tschopp J., Abbas A.K. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity. 8:1998;615-623
22. Wang R., Rogers A.M., Rush B.J., Russell J.H. Induction of sensitivity to activation-induced death in primary CD4+ cells: a role for interleukin-2 in the negative regulation of responses by mature CD4+ T cells. Eur J Immunol. 26:1996;2263-2270
23. Dai Z., Arakelov A., Wagener M., Konieczny B.T., Lakkis F.G. The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death. J Immunol. 163:1999;3131-3137
24. Chu C.L., Chen S.S., Wu T.S., Kuo S.C., Liao N.S. Differential effects of IL-2 and IL-15 on the death and survival of activated TCR gamma delta+ intestinal intraepithelial lymphocytes. J Immunol. 162:1999;1896-1903
25. Villinger F., Bucur S., Chikkala N.F., Brar S.S., Bostik P., Mayne A.E., et al. In vitro and in vivo responses to interleukin 12 are maintained until the late SIV infection stage but lost during AIDS. AIDS Res Hum Retroviruses. 16:2000;751-763
26. Bucur S.Z., Lackey D.A., Adams J.W., Lee M.E., Villinger F., Mayne A., et al. Hematologic and virologic effects of lineage-specific and non-lineage-specific recombinant human and rhesus cytokines in a cohort of SIVmac239-infected macaques. AIDS Res Hum Retroviruses. 14:1998;651-660
27. Bucur S.Z., Gillespie T.W., Lee M.E., Adams J.W., Bray R.A., Villinger F., et al. Hematopoietic response to lineage-non-specific (rrIL-3) and lineage-specific (rhG-CSF, rhEpo, rhTpo) cytokine administration in SIV-infected rhesus macaques is related to stage of infection. J Med Primatol. 29:2000;47-56
28. Ansari A.A., Bostik P., Mayne A.E., Villinger F. Failure to expand influenza and tetanus toxoid memory T cells in vitro correlates with disease course in SIV infected rhesus macaques. Cell Immunol. 210:2001;125-142
29. Folks T., Rowe T., Villinger F., Parekh B., Mayne A., Anderson D., et al. Immune stimulation may contribute to enhanced progression of SIV induced disease in rhesus macaques. J Med Primatol. 26:1997;181-189
30. Villinger F., Rowe T., Parekh B.S., Green T.A., Mayne A.E., Grimm B., et al. Chronic immune stimulation accelerates SIV-induced disease progression. J Med Primatol. 30:2001;254-259
31. Villinger F., Brar S.S., Mayne A., Chikkala N., Ansari A.A. Comparative sequence analysis of cytokine genes from human and nonhuman primates. J Immunol. 155:1995;3946-3954
32. Villinger F., Hunt D., Mayne A., Vuchetich M., Findley H., Ansari A.A. Qualitative and quantitative studies of cytokines synthesized and secreted by non-human primate peripheral blood mononuclear cells. Cytokine. 5:1993;469-479
33. Amara R.R., Villinger F., Altman J.D., Lydy S.L., O'Neill S.P., Staprans S.I., et al. Control of a mucosal challenge and prevention of AIDS in rhesus macaques by a multiprotein DNA/MVA vaccine. Science. 292:2001;69-74
34. Villinger F., Switzer W.M., Parekh B.S., Otten R.A., Adams D., Shanmugam V., et al. Induction of long-term protective effects against heterologous challenge in SIVhu-infected macaques. Virology. 278:2000;194-206
35. Villinger F., Brice G.T., Mayne A.E., Bostik P., Mori K., June C.H., et al. Adoptive transfer of simian immunodeficiency virus (SIV) naive autologous CD4(+) cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status. Blood. 99:2002;590-599
36. Villinger F., Mayne A.E., Bostik P., Mori K., Jensen P.E., Ahmed R., et al. Evidence for antibody-mediated enhancement of simian immunodeficiency virus (SIV) Gag antigen processing and cross presentation in SIV-infected rhesus macaques. J Virol. 77:2003;10-24
37. Strijbosch L.W., Buurman W.A., Does R.J., Zinken P.H., Groenewegen G. Limiting dilution assays. Experimental design and statistical analysis. J Immunol Methods. 97:1987;133-140
38. Lanzavecchia A., Sallusto F. Progressive differentiation and selection of the fittest in the immune response. Nat Rev Immunol. 2:2002;982-987
39. Lefrancois L., Masopust D. T cell immunity in lymphoid and non-lymphoid tissues. Curr Opin Immunol. 14:2002;503-508
40. Sprent J., Surh C.D. T cell memory. Annu Rev Immunol. 20:2002;551-579
41. Whitmire J.K., Murali-Krishna K., Altman J., Ahmed R. Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements. Philos Trans R Soc Lond B Biol Sci. 355:2000;373-379
42. Pasquini S., Xiang Z., Wang Y., He Z., Deng H., Blaszczyk-Thurin M., et al. Cytokines and costimulatory molecules as genetic adjuvants. Immunol Cell Biol. 75:1997;397-401
43. Bukowski R.M., Olencki T., Wang Q., Peereboom D., Budd G.T., Elson P., et al. Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of response. J Immunother. 20:1997;301-311
44. Paredes R., Lopez Benaldo de Quiros J.C., Fernandez-Cruz E., Clotet B., Lane H.C. The potential role of interleukin-2 in patients with HIV infection. AIDS Rev. 4:2002;36-40
45. Smith K.A. Low-dose daily interleukin-2 immunotherapy: accelerating immune restoration and expanding HIV-specific T-cell immunity without toxicity. AIDS. 15(2):2001;S28-S35
46. Hoffman S.L., Crutcher J.M., Puri S.K., Ansari A.A., Villinger F., Franke E.D., et al. Sterile protection of monkeys against malaria after administration of interleukin-12. Nat Med. 3:1997;80-83
47. Ansari A.A., Mayne A.E., Sundstrom J.B., Bostik P., Grimm B., Altman J.D., et al. Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques. J Virol. 76:2002;1731-1743
48. Xing Z., Wang J. Consideration of cytokines as therapeutics agents or targets. Curr Pharm Des. 6:2000;599-611
49. Zwierzina H. Practical aspects of cytokine therapy. Stem Cells. 11:1993;144-153
50. Natarajan V., Lempicki R.A., Sereti I., Badralmaa Y., Adelsberger J.W., Metcalf J.A., et al. Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection. Proc Natl Acad Sci USA. 99:2002;10712-10717
51. Sereti I., Herpin B., Metcalf J.A., Stevens R., Baseler M.W., Hallahan C.W., et al. CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients. AIDS. 15:2001;1765-1775
52. Dai Z., Konieczny B.T., Lakkis F.G. The dual role of IL-2 in the generation and maintenance of CD8+ memory T cells. J Immunol. 165:2000;3031-3036
53. Oh S., Berzofsky J.A., Burke D.S., Waldmann T.A., Perera L.P. Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity. Proc Natl Acad Sci USA. 100:2003;3392-3397